21868-80-4Relevant academic research and scientific papers
Novel Sulfonaminoquinoline Hepcidin Antagonists
-
, (2012/09/05)
The present invention relates to novel hepcidin antagonists, pharmaceutical compositions comprising them and the use thereof as medicaments for the use in the treatment of iron metabolism disorders, such as, in particular, iron deficiency diseases and anemias, in particular anemias in connection with chronic inflammatory diseases.
COMPOUNDS THAT INHIBIT NFκB ACTIVITY
-
Page/Page column 5; 34, (2010/05/14)
The present invention relates to compounds with activity as BACE1 and NFκB modulators, and methods for treating, preventing, or ameliorating neurodegenerative diseases, such as Alzheimer's disease. The present invention is also directed to the treatment o
Convenient preparation of N-8-quinolinyl benzenesultams as novel NF-κB inhibitors
Xie, Yuli,Gong, Gangli,Liu, Yidong,Deng, Shixian,Rinderspacher, Alison,Branden, Lars,Landry, Donald W.
, p. 2320 - 2323 (2008/09/18)
An efficient synthesis of a series of N-8-quinolinyl benzenesultams as novel NF-κB inhibitors was described via diazotization-induced cyclization of easily accessible N-8-quinolinyl-2-aminobenzenesulfonamides.
